Updates are available Correction dated 2022-03-08
Click to view Correction: https://doi.org/10.1038/s41398-022-01845-w
-
Authors
Carvalho Henriques, Beatriz https://orcid.org/0000-0002-7139-6642
Buchner, Avery https://orcid.org/0000-0001-9574-4763
Hu, Xiuying https://orcid.org/0000-0001-8158-4412
Wang, Yabing
Yavorskyy, Vasyl https://orcid.org/0000-0001-5131-4374
Wallace, Keanna https://orcid.org/0000-0002-0864-6362
Dong, Rachael https://orcid.org/0000-0003-3015-701X
Martens, Kristina https://orcid.org/0000-0002-3957-0647
Carr, Michael S. https://orcid.org/0000-0002-8593-0009
Behroozi Asl, Bahareh https://orcid.org/0000-0003-0682-4417
Hague, Joshua https://orcid.org/0000-0001-9993-6674
Sivapalan, Sudhakar https://orcid.org/0000-0001-8721-5896
Maier, Wolfgang
Dernovsek, Mojca Z. https://orcid.org/0000-0001-5344-7007
Henigsberg, Neven https://orcid.org/0000-0002-5303-1834
Hauser, Joanna https://orcid.org/0000-0002-6621-3493
Souery, Daniel
Cattaneo, Annamaria https://orcid.org/0000-0002-9963-848X
Mors, Ole
Rietschel, Marcella https://orcid.org/0000-0002-5236-6149
Pfeffer, Gerald https://orcid.org/0000-0002-7657-7098
Hume, Stacey https://orcid.org/0000-0002-3217-3032
Aitchison, Katherine J. https://orcid.org/0000-0002-1107-3024
- License Information
-
More Information
Article History
Received: 7 December 2020
Accepted: 28 October 2021
First Online: 22 November 2021
Change Date: 8 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41398-022-01845-w
Competing interests
: NH has participated in research supported by CSF project No. IP-09-2014-2979. DS has received grant/research support from Janssen and Lundbeck and has served as a consultant or on advisory boards for Janssen and Lundbeck. KJA is a member of the Clinical Pharmacogenetics Implementation Consortium and the Pharmacogene Variation Consortium, has received two research grants in the last two years from Janssen Inc., Canada (fellowship grants for trainees). All other authors have nothing to disclose.
